Economic Evaluation in Genomic and Precision Medicine

• Broschiertes Buch

Produktbeschreibung

Economic Evaluation in Genomic and Precision Medicine provides an in-depth examination of essential concepts, protocols and applications of economic evaluation in genomic and precision medicine. Contributions from leading international medical geneticists and health economists compile new ways to effectively assess the costs and outcomes of different genomic care pathways, implement cost-effective medical interventions, and enhance the value of genomic and precision healthcare. Foundational chapters and discipline-specific case studies cover topics ranging from the economic analysis of genomic trial design, to health technology assessment of next-generation sequencing, ethical aspects, economic policy in genomic medicine, and pricing and reimbursement in clinical genomics.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Translational and Applied Genomics
• Verlag: Elsevier Science Publishing Co Inc
• Seitenzahl: 170
• Erscheinungstermin: 24. April 2023
• Englisch
• Abmessung: 191mm x 234mm x 11mm
• Gewicht: 364g
• ISBN-13: 9780128133828
• ISBN-10: 0128133821
• Artikelnr.: 58261663

Inhaltsangabe

1. Introduction to economic evaluation in health sciences
2. Foundations of pharmacogenomics and personalized medicine
3. Economic evaluation of genome-guided treatment in oncology
4. Economic evaluation of rare diseases and the diagnostic odyssey
5. Economic analysis of pharmacogenetic testing for HLA-based adverse drug
reactions
6. Economic evaluation of personalized medicine interventions in medium-
and low-income countries with poor proliferation of genomics and genetic
testing
7. Theoretical models for economic evaluation in genomic and personalized
medicine
8. Using big data in economic evaluations in genomics: Challenges and
opportunities
9. Assessing the stakeholder environment and views towards implementation
of personalized medicine in a healthcare setting
10. Feasibility for pricing, budget allocation, and reimbursement of
personalized medicine interventions